Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-018428
Filing Date
2019-06-27
Accepted
2019-06-27 17:15:02
Documents
2
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2780
2 EX-24 DOCUMENT attachment1.htm EX-24 4225
  Complete submission text file 0000899243-19-018428.txt   8324
Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Pande Atul (Reporting) CIK: 0001643071 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38958 | Film No.: 19926281

Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

EIN.: 270605902
SIC: 2834 Pharmaceutical Preparations